Drug Approval | September 06, 2024
Strides receive USFDA approval for Theophylline ER tablets, 300 mg and 450 mg
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Subscribe To Our Newsletter & Stay Updated
